| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
TLK1 |
TLK1, KIAA0137: Serine/threonine-protein kinase tousled-like 1 |
23.660 |
Evidence |
|
| RB1 |
RB1: Retinoblastoma-associated protein |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
23.660 |
Evidence |
|
| RB1 |
RB1: Retinoblastoma-associated protein |
MTA1 |
MTA1: Metastasis-associated protein MTA1 |
23.660 |
Evidence |
|
| EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
EFNB3 |
EFNB3, EPLG8, LERK8: Ephrin-B3 precursor |
23.630 |
Evidence |
|
| EFNA4 |
EFNA4, EPLG4, LERK4: Ephrin-A4 precursor |
EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
23.630 |
Evidence |
|
| EFNA3 |
EFNA3, EFL2, EPLG3, LERK3: Ephrin-A3 precursor |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
23.630 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
EFNA4 |
EFNA4, EPLG4, LERK4: Ephrin-A4 precursor |
23.630 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
23.630 |
Evidence |
|
| STX1A |
STX1A, STX1: Syntaxin-1A |
VAMP8 |
VAMP8: Vesicle-associated membrane protein 8 |
23.610 |
Evidence |
|
| SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
23.580 |
Evidence |
|
| BIK |
BIK, NBK: Bcl-2-interacting killer |
BAK1 |
IPI00003352 |
23.580 |
Evidence |
|
| KCNJ10 |
KCNJ10: ATP-sensitive inward rectifier potassium channel 10 |
KCNJ15 |
KCNJ15, KCNJ14: ATP-sensitive inward rectifier potassium channel 15 |
23.580 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
CD1E |
CD1E, RP11-101J8.5-005, hCG_1640053: CD1e molecule |
23.580 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
TCF12 |
TCF12, HEB, HTF4: Transcription factor 12 |
23.580 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
CD1E |
CD1E, RP11-101J8.5-005, hCG_1640053: CD1e molecule |
23.580 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
CD1E |
CD1E, RP11-101J8.5-005, hCG_1640053: CD1e molecule |
23.580 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
CD1B |
CD1B: T-cell surface glycoprotein CD1b precursor |
23.580 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
HCK |
IPI00029769 |
23.580 |
Evidence |
|
| HRK |
HRK, BID3: Activator of apoptosis harakiri |
BIK |
BIK, NBK: Bcl-2-interacting killer |
23.580 |
Evidence |
|
| F10 |
F10: Coagulation factor X precursor |
ITGA2B |
ITGA2B, GP2B, ITGAB: Integrin alpha-IIb precursor |
23.500 |
Evidence |
|
| F10 |
F10: Coagulation factor X precursor |
LAMC1 |
LAMC1, LAMB2: Laminin subunit gamma-1 precursor |
23.500 |
Evidence |
|
| F10 |
F10: Coagulation factor X precursor |
THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
23.500 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
GAD2 |
GAD2, GAD65: Glutamate decarboxylase 2 |
23.500 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
CNTN2 |
CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor |
23.500 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
LAMC1 |
LAMC1, LAMB2: Laminin subunit gamma-1 precursor |
23.500 |
Evidence |
|